# US 2021/0333436 A1 · Antioxidant Contact Lens

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2021/0333436 A1
- Document ID: US20210333436A1
- Status: Published application
- Kind: A1
- Application number: 17/228,748
- Filed: 2021-04-13
- Published: 2021-10-28
- Earliest claimed: 2020-04-27
- Assignees: CooperVision International Limited
- Applicants: CooperVision International Limited
- Inventors: Inna MALTSEVA; Nancy J. KEIR; Andrew LUK; Victoria ROGERS
- Web page: https://patentgrep.com/patent/US20210333436A1

## CPC

- G02B 1/043: {Contact lenses}
- A45C 11/005: {Contact lens cases (A45C11/046 takes precedence)}
- A61K 9/0051: {Ocular inserts or implants}
- A61K 31/355: Tocopherols, e.g. vitamin E
- B29D 11/00067: {Hydrating contact lenses}
- B29D 11/00096: {for delivering compositions, e.g. drugs to the eye}
- C08J 3/075: Macromolecular gels
- C08K 5/1545: Six-membered rings
- C08J 2333/26: Homopolymers or copolymers of acrylamide or methacrylamide
- C08J 2383/04: Polysiloxanes
- G02B: OPTICAL ELEMENTS, SYSTEMS OR APPARATUS
- A45C: PURSES; LUGGAGE; HAND CARRIED BAGS
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- B29D: PRODUCING PARTICULAR ARTICLES FROM PLASTICS OR FROM SUBSTANCES IN A PLASTIC STATE (making granules B29B9/00; making preforms B29B11/00)
- C08J: WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H (working, e.g. shaping, of plastics B29)
- C08K: Use of inorganic or non-macromolecular organic substances as compounding ingredients (paints, inks, varnishes, dyes, polishes, adhesives C09)

## Abstract

A contact lens having antioxidant properties is described as well as methods of manufacturing the same. The contact lens can be present in a sealed contact lens package. The seal contact lens package can include at least a) a plastic base member having a cavity; b) a contact lens packaging solution in the cavity; c) a sterile, unworn contact lens immersed in the contact lens packaging solution in the cavity; and d) a cover that forms a liquid-tight seal with the plastic base member. As an example, the unworn contact lens is a silicone hydrogel contact lens having present therein vitamin E. The vitamin E is non-releasable from the unworn contact lens and the contact lens packaging solution has less than 1 ppm of vitamin E present. The vitamin E is trapped, embedded, absorbed, or non-covalently attached in the unworn contact lens.

## Claims

### Claim 1

An unworn antioxidant contact lens immersed in a packaging solution and sterilely sealed in a package, said contact lens comprising a silicone hydrogel and amount of vitamin E embedded within the silicone hydrogel effective to provide at least a 50% reduction in lipid peroxidation relative to a control contact lens lacking the vitamin E when measured in a TBARS assay, wherein the antioxidant contact lens is free of a bioactive agent having a release profile attenuated by the vitamin E.

### Claim 2

An unworn antioxidant contact lens immersed in a packaging solution and sterilely sealed in a package, said contact lens comprising a silicone hydrogel and amount of vitamin E embedded within the silicone hydrogel effective to provide at least a 50% reduction in lipid peroxidation relative to a control contact lens lacking the vitamin E when measured in a TBARS assay, wherein the antioxidant contact lens has (a) an ophthalmically-acceptable surface wettability in the absence of a post curing surface treatment and (b) an advancing contact angle that is no more than 10° greater than the control lens.

### Claim 3

An unworn antioxidant contact lens immersed in a packaging solution and sterilely sealed in a package, said contact lens comprising a silicone hydrogel and 10 μg to 1000 μg of vitamin E embedded in the silicone hydrogel, wherein the antioxidant contact lens (a) has a heat stability that is no greater than a control contact lens lacking the vitamin E and (b) is free of a bioactive agent having a release profile attenuated by the vitamin E.

### Claim 4 (depends on 1)

The unworn antioxidant contact lens of claim 1, wherein the amount of vitamin E is 10 μg to 1000 μg per 25 mg of the antioxidant contact lens when fully hydrated.

### Claim 5 (depends on 1)

The unworn antioxidant contact lens of claim 1 having a % equilibrium water content (% EWC) that is no less than 5% that of the control lens.

### Claim 6 (depends on 1)

The unworn antioxidant contact lens of claim 1 having between 40% to 60% EWC.

### Claim 7 (depends on 1)

The unworn antioxidant contact lens of claim 1 having a lens diameter within ±0.2 mm that of the control lens.

### Claim 8 (depends on 1)

The unworn antioxidant contact lens of claim 1 having an advancing contact angle that is no more than 5° greater than the control lens.

### Claim 9 (depends on 1)

The unworn antioxidant contact lens of claim 1 wherein the reduction in lipid peroxidation is at least 80%.

### Claim 10

A method of manufacturing an antioxidant contact lens comprising polymerizing a monomer mixture comprising at least one silicone monomer and at least one hydrophilic monomer to provide a lens-shaped polymerization product; extracting the polymerization product in an organic solvent comprising 0.2 mg/mL to 10 mg/mL vitamin E; hydrating the polymerization product to form a silicone hydrogel contact lens; and sterilely sealing the contact lens in a package, wherein the antioxidant contact lens (a) provides at least a 80% reduction in lipid peroxidation relative to a control contact lens lacking the vitamin E when measured in a TBARS assay, (b) has a heat stability that is no greater than that of the control contact lens, and (c) is free of a bioactive agent having a release profile attenuated by the vitamin E.

### Claim 11

A sealed contact lens package comprising:
a) a plastic base member having a cavity;
b) a contact lens packaging solution in said cavity;
c) a sterile, unworn contact lens immersed in said contact lens packaging solution in said cavity; and
d) a cover that forms a liquid-tight seal with the plastic base member,
wherein the unworn contact lens is a silicone hydrogel contact lens having present therein at least 10 μg of vitamin E per 25 mg of the sterile, unworn contact lens when fully hydrated and 0 μg of a bioactive agent, and said vitamin E is non-releasable from said unworn contact lens and said contact lens packaging solution has less than 1 ppm of vitamin E present.

### Claim 12 (depends on 11)

The sealed contact lens package of claim 11, wherein said vitamin E is trapped, embedded, absorbed, or non-covalently attached in said unworn contact lens.

### Claim 13 (depends on 11)

The sealed contact lens package of claim 11, wherein said vitamin E provides at least a 50% reduction in lipid peroxidation relative to a control contact lens lacking the vitamin E when measured in a TBARS assay.

### Claim 14 (depends on 11)

The sealed contact lens package of claim 11, wherein said unworn contact lens is in the absence of any agent that provides antioxidant properties except for said vitamin E.

### Claim 15 (depends on 11)

The sealed contact lens package of claim 11, wherein the unworn contact lens has (a) an ophthalmically-acceptable surface wettability in the absence of a post curing surface treatment or (b) an advancing contact angle that is no more than 10° greater than the control lens, or both (a) and (b).

### Claim 16 (depends on 11)

The sealed contact lens package of claim 11, wherein the unworn contact lens (a) has a heat stability that is no greater than a control contact lens lacking the vitamin E.

### Claim 17 (depends on 11)

The sealed contact lens package of claim 11, wherein the unworn contact lens has about the same coefficient of friction after an overnight wash compared to a control contact lens lacking the vitamin E.

### Claim 18 (depends on 11)

The sealed contact lens package of claim 11, wherein said sterile, unworn contact lens has at least one silicone hydrogel property that is same or substantially the same as a control lens lacking said vitamin E.

### Claim 19 (depends on 18)

The sealed contact lens package of claim 18, wherein said silicone hydrogel property is surface wettability, advancing contact angle, % EWC, lens diameter, or amount of water or aqueous fluid needed to obtain a fully hydrated contact lens.

### Claim 20 (depends on 1)

The unworn antioxidant contact lens of claim 1, wherein the amount of vitamin E is effective to reduce generation of reactive oxygen species (ROS) from human corneal epithelial cells (HCECs) contacted in vitro with H2O2 relative to the control contact lens when measured in an HCEC viability assay.

### Claim 21 (depends on 11)

The sealed contact lens package of claim 11, wherein the vitamin E is effective to reduce generation of reactive oxygen species (ROS) from human corneal epithelial cells (HCECs) contacted in vitro with H2O2 relative to the control contact lens when measured in an HCEC viability assay.

### Claim 22

A method to control lipid peroxidation from tear film in an eye of a person wearing a contact lens, said method comprising inserting a sterile, unworn contact lens in the eye of said person to correct vision in said eye of said person, and wherein the sterile, unworn contact lens is a silicone hydrogel contact lens having therein an amount of vitamin E that is at least 20 μg of vitamin E per 25 mg of the sterile, unworn contact lens when fully hydrated and 0 μg of a bioactive agent, and said vitamin E is non-releasable from said sterile, unworn contact lens when worn in the eye.

### Claim 23 (depends on 22)

The method of claim 22, wherein said method provides at least a 50% reduction in said lipid peroxidation relative to a control contact lens lacking the vitamin E when measured in a TBARS assay.

### Claim 24 (depends on 22)

The method of claim 22, wherein said vitamin E is trapped, embedded, absorbed, or non-covalently attached in said sterile, unworn contact lens.

### Claim 25 (depends on 22)

The method of claim 22, wherein said method is in the absence of utilizing any agent that provides antioxidant properties except for said vitamin E.
